Home > Healthcare > Medical Devices > Therapeutic Devices > Left Atrial Appendage Closure Devices Market

Left Atrial Appendage Closure Devices Market Share

Report ID: GMI3960
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Left Atrial Appendage Closure Devices Market Share

The left atrial appendage closure devices industry is characterized by the presence of several established and emerging players that offer a variety of products across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.

Left Atrial Appendage Closure Devices Market Companies

Prominent players operating in the left atrial appendage closure devices industry include:

Abbott Laboratories
ArtiCure, Inc.
Boston Scientific Corporation
Cardia, Inc.
Johnson & Johnson
LifeTech Scientific
Nanjing YDB Technology Co., Ltd
Occlutech

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The left atrial appendage closure devices market was valued at USD 1.6 billion in 2023 and is anticipated to witness growth at 14.1% CAGR between 2024-2032 driven by the increasing prevalence of atrial fibrillation.

The endocardial segment held 83.7% share in 2023 due to the minimally invasive nature of the procedure and the associated benefits.

North America left atrial appendage closure devices market size was valued at USD 750.3 million in 2023 and is predicted to grow at 13.7% CAGR during 2024-2032 attributed to the presence of leading medical device manufacturers.

Abbott Laboratories, ArtiCure, Inc., Boston Scientific Corporation, Cardia, Inc., Johnson & Johnson, LifeTech Scientific, Nanjing YDB Technology Co., Ltd, and Occlutech among others.